Lucie M Turcotte

20082022
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2008 2019

Filter
Review article
2018
7 Citations (Scopus)

Risk, risk factors, and surveillance of subsequent malignant neoplasms in survivors of childhood cancer: A review

Turcotte, L. M., Neglia, J. P., Reulen, R. C., Ronckers, C. M., Van Leeuwen, F. E., Morton, L. M., Hodgson, D. C., Yasui, Y., Oeffinger, K. C. & Henderson, T. O., Jul 20 2018, In : Journal of Clinical Oncology. 36, 21, p. 2145-2152 8 p.

Research output: Contribution to journalReview article

Survivors
Neoplasms
Genetic Predisposition to Disease
Anthracyclines
Therapeutics
2017
Multiple Myeloma
Young Adult
Age Groups
Plasmacytoma
Differential Diagnosis

Subsequent malignant neoplasms in the survivor of childhood cancer: Where we have been and where we are going?

Turcotte, L. M. & Neglia, J. P., Oct 1 2017, In : Future Oncology. 13, 23, p. 2013-2016 4 p.

Research output: Contribution to journalReview article

Epidemiology
Neoplasms
54 Citations (Scopus)

Temporal trends in treatment and subsequent neoplasm risk among 5-year survivors of childhood cancer, 1970-2015

Turcotte, L. M., Liu, Q., Yasui, Y., Arnold, M. A., Hammond, S., Howell, R. M., Smith, S. A., Weathers, R. E., Henderson, T. O., Gibson, T. M., Leisenring, W., Armstrong, G. T., Robison, L. L. & Neglia, J. P., Feb 28 2017, In : JAMA - Journal of the American Medical Association. 317, 8, p. 814-824 11 p.

Research output: Contribution to journalReview article

Survivors
Neoplasms
Therapeutics
Meningioma
Skin Neoplasms
2016
6 Citations (Scopus)
Cell Transplantation
Survivors
Therapeutics
Microbiota
Health